FRONTEO,Inc. (2158)
Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| Period End | EBITDA (Million JPY) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 873 | +76.18% |
| Mar 31, 2024 | 495 | -182.75% |
| Mar 31, 2023 | -599 | -123.18% |
| Mar 31, 2022 | 2,582 | +95.39% |
| Mar 31, 2021 | 1,322 | -84442.76% |
| Mar 31, 2020 | -2 | -100.15% |
| Mar 31, 2019 | 1,062 | -11.00% |
| Mar 31, 2018 | 1,193 | -812.48% |
| Mar 31, 2017 | -167 | -117.58% |
| Mar 31, 2016 | 953 | +11.58% |
| Mar 31, 2015 | 854 |